Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

ACC 2024 Congress

Catch up on all the top stories and latest evidence in cardiology research with our ACC 2024 Congress hub page.
ADVANCED SEARCH
Log in
Top
Surgical Endoscopy
Published in: Surgical Endoscopy 9/2017

01-09-2017

Endotherapy in case of relapse of neoplastic Barrett’s esophagus after successful initial endoscopic resection

Authors: Sébastien Godat, Fabrice Caillol, Aurélie Autret, Erwan Bories, Christian Pesenti, Jean Philippe Ratone, Chiara De Cassan, Flora Poizat, Marc Giovannini

Published in: Surgical Endoscopy | Issue 9/2017

Login to get access

Abstract

Background

Endotherapy in cases of neoplastic Barrett esophagus (BE) relapse after successful initial endoscopic management is commonly accepted, but few studies analyze this topic and also take into account the metachronous lesions.

Aims

To evaluate the efficiency of endotherapy in the case of neoplastic BE relapse after successful complete endoscopic eradication of neoplastic BE and metaplastic BE.

Methods

Retrospective review of medical records was collected in a computerized and prospective manner between 2000 and 2015, in a single tertiary care center. Recurrence was defined by histological presence of high-grade dysplasia or superficial adenocarcinoma at least 6 months after the end of successful initial endotherapy.

Results

Eighteen patients were assessed (1F/17 M). Delay between initial treatment and relapse was 16.6 months (range 6–33). Endotherapy for relapse obtained a sustained and complete remission for 8/18 (44%) patients, with an average endoscopic follow-up of 28 months. The complication rate of endotherapy was 6%. Surgical management was required in 33% (2 pT2N0M0, 2 pTisN0M0, 1 pTm2N0M0 and 1 pTm3N0M0) and salvage radiochemotherapy in 17% (3/18). One patient treated by 6 sessions of ER was considered as a failure given the multiple sessions of endotherapy. Multivariate analysis showed that length of BE (>5 cm), late stenosis adverse events and the quality of vertical margin during initial ER are predictive factors for disease-free survival (p value < 0.01, Hazard Ratio up to 0.076).

Conclusion

Endotherapy could be a treatment for management of neoplastic BE relapse, but should be carefully used, with strict follow-up.
Literature
1.
Bennett C, Vakil N, Bergman J et al (2012) Consensus statements for management of Barrett’s dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology 143(2):336–346CrossRefPubMedPubMedCentral
2.
Van Vilsteren FG, Pouw RE, Seewald S et al (2011) Stepwise radical endoscopic resection versus radiofrequency ablation for Barrett’s oesophagus with high-grade dysplasia or early cancer: a multicentre randomised trial. Gut 60(6):765–773CrossRefPubMed
3.
Alvarez Herrero L, van Vilsteren FG, Pouw RE et al (2011) Endoscopic radiofrequency ablation combined with endoscopic resection for early neoplasia in Barrett’s esophagus longer than 10 cm. Gastrointest Endosc 73(4):682–690CrossRefPubMed
4.
Chennat J, Konda VJ, Ross AS et al (2009) Complete Barrett’s eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma–an American single-center experience. Am J Gastroenterol 104(11):2684–2692CrossRefPubMed
5.
Pech O, Bollschweiler E, Manner H et al (2011) Comparison between endoscopic and surgical resection of mucosal esophageal adenocarcinoma in Barrett’s esophagus at two high-volume centers. Ann Surg 254(1):67–72CrossRefPubMed
6.
Dunbar KB, Spechler SJ (2012) The risk of lymph-node metastases in patients with high-grade dysplasia or intramucosal carcinoma in Barrett’s esophagus: a systematic review. Am J Gastroenterol 107(6):850–862CrossRefPubMedPubMedCentral
7.
Höbel S, Dautel P, Baumbach R et al (2015) Single center experience of endoscopic submucosal dissection (ESD) in early Barrett´s adenocarcinoma. Surg Endosc 29(6):1591–1597CrossRefPubMed
8.
Kim HP, Bulsiewicz WJ, Cotton CC et al (2012) Focal endoscopic mucosal resection before radiofrequency ablation is equally effective and safe compared with radiofrequency ablation alone for the eradication of Barrett’s esophagus with advanced neoplasia. Gastrointest Endosc 76(4):733–739CrossRefPubMedPubMedCentral
9.
Haidry RJ, Butt MA, Dunn JM et al (2014) Improvement over time in outcomes for patients undergoing endoscopic therapy for Barrett’s oesophagus-related neoplasia: 6-year experience from the first 500 patients treated in the UK patient registry. Gut pii: gutjnl-2014-308501
10.
Caillol F, Bories E, Pesenti C et al (2012) Radiofrequency ablation associated to mucosal resection in the oesophagus: experience in a single centre. Clin Res Hepatol Gastroenterol 36(4):371–377CrossRefPubMed
11.
Blevins CH, Iyer PG (2015) Endoscopic therapy for Barrett’s oesophagus. Best Pract Res Clin Gastroenterol 29(1):167–177CrossRefPubMed
12.
Anders M, Bähr C, El-Masry MA et al (2014) Long-term recurrence of neoplasia and Barrett’s epithelium after complete endoscopic resection. Gut 63(10):1535–1543CrossRefPubMed
13.
Gupta M, Iyer PG, Lutzke L et al (2013) Recurrence of esophageal intestinal metaplasia after endoscopic mucosal resection and radiofrequency ablation of Barrett’s esophagus: results from a US multicenter consortium. Gastroenterology 145(1):79-86.e1
14.
Giovannini M, Bories E, Pesenti C et al (2004) Circumferential endoscopic mucosal resection in Barrett’s esophagus with high-grade intraepithelial neoplasia or mucosal cancer. Preliminary results in 21 patients. Endoscopy 36(9):782–787CrossRefPubMed
15.
Pech O, May A, Manner H et al (2014) Long-term efficacy and safety of endoscopic resection for patients with mucosal adenocarcinoma of the esophagus. Gastroenterology 146(3):652-660.e1
16.
Neuhaus H, Terheggen G, Rutz EM et al (2012) Endoscopic submucosal dissection plus radiofrequency ablation of neoplastic Barrett’s esophagus. Endoscopy 44(12):1105–1113CrossRefPubMed
17.
Pouw RE, Wirths K, Eisendrath P et al (2010) Efficacy of radiofrequency ablation combined with endoscopic resection for barrett’s esophagus with early neoplasia. Clin Gastroenterol Hepatol 8(1):23–29CrossRefPubMed
18.
Phoa KN, Pouw RE, van Vilsteren FG et al (2013) Remission of Barrett’s esophagus with early neoplasia 5 years after radiofrequency ablation with endoscopic resection: a Netherlands cohort study. Gastroenterology 145(1):96–104CrossRefPubMed
19.
Kagemoto K, Oka S, Tanaka S et al (2014) Clinical outcomes of endoscopic submucosal dissection for superficial Barrett’s adenocarcinoma. Gastrointest Endosc 80(2):239–245CrossRefPubMed
20.
Haidry RJ, Butt MA, Dunn J et al (2013) Radiofrequency ablation for early oesophageal squamous neoplasia: outcomes form United Kingdom registry. World J Gastroenterol 19(36):6011–6019CrossRefPubMedPubMedCentral
21.
Nozaki I, Kato K, Igaki H et al (2015) Evaluation of safety profile of thoracoscopic esophagectomy for T1bN0M0 cancer using data from JCOG0502: a prospective multicenter study. Surg Endosc 29:3519–3526CrossRefPubMedPubMedCentral
22.
Filip B, Scarpa M, Cavallin F et al (2015) Postoperative outcome after oesophagectomy for cancer: nutritional status is the missing ring in the current prognostic scores. Eur J Surg Oncol 41(6):787–794CrossRefPubMed
23.
Wolfsen HC, Hemminger LL, DeVault KR (2004) Recurrent Barrett’s esophagus and adenocarcinoma after esophagectomy. BMC Gastroenterol 25(4):18CrossRef
24.
Pech O, Behrens A, May A et al (2008) Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett’s oesophagus. Gut 57(9):1200–1206CrossRefPubMed
Metadata
Title
Endotherapy in case of relapse of neoplastic Barrett’s esophagus after successful initial endoscopic resection
Authors
Sébastien Godat
Fabrice Caillol
Aurélie Autret
Erwan Bories
Christian Pesenti
Jean Philippe Ratone
Chiara De Cassan
Flora Poizat
Marc Giovannini
Publication date
01-09-2017
Publisher
Springer US
Published in
Surgical Endoscopy / Issue 9/2017
Print ISSN: 0930-2794
Electronic ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-016-5409-5

Other articles of this Issue 9/2017

Surgical Endoscopy 9/2017 Go to the issue

OriginalPaper

Five hundred consecutive laparoscopic common bile duct explorations: 5-year experience at a single institution

OriginalPaper

The effect of postoperative complications on survival of patients after minimally invasive esophagectomy for esophageal cancer

OriginalPaper

Infrahepatic inferior vena cava clamping with Pringle maneuvers for laparoscopic extracapsular enucleation of giant liver hemangiomas

OriginalPaper

Colorectal ESD in day surgery

Editorial

Open Researcher and Contributor ID (ORCID): vital for surgical endoscopy

OriginalPaper

OR fire virtual training simulator: design and face validity